In the realm of Head and Neck radiotherapy, patient immobilization is paramount to ensure treatment accuracy and minimize risks. The OPEN (Optimising Patient Experience in Head and Neck Radiotherapy) Phase III trial, conducted at St. Luke’s Hospital, Dublin, Ireland, has provided compelling clinical evidence supporting the efficacy of Orfit's open face hybrid masks in achieving intrafraction motion stability comparable to traditional closed facemasks.
The OPEN Phase III trial study compared intrafraction motion across different facemask designs:
Both CBCT and SGRT were used to assess patient motion during treatment. Importantly, the study found that both Orfit's 3-point and 5-point open-face masks provided intrafraction stability comparable to traditional closed facemasks, demonstrating that improved comfort does not come at the expense of precision.
